NYS:BIIB is under Algo Engine buy conditions and is a current holding in our US model portfolio.
Biogen is an NYSE listed biotech company specializing in the discovery, development, and delivery of therapies for the treatment of neurological disease to patients worldwide.
You're not a member! Trial today
The stock rallied 11% overnight after the FDA accepted an application for Biogen’s experimental Alzheimer’s drug.
